Syntheticgestalt

Provider of AI-based cheminformatics platform for drug discovery

placeLondon, England, United Kingdom calendar_todayFounded 2018 groups7 employees language syntheticgestalt.com

Registered entities

Innovation

1 patent family — focus: Physics & computing; filing pace dormant. Cited 4 times.

YearFilings
20201

Social engagement

Social engagement: 2.1K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Incubate Fund, Mitsui Sumitomo Insurance Venture Capital.

Investor typeCountShare
Venture capital3100%

Recent activity

19 Mar 2026
Expansion
H1O Hamamatsucho, Minato-ku
19 Mar 2026
Event
AI Leader's Meetup 2026 Spring
7 Nov 2025
Event
CEATEC 2025
Coming soon